Compounds > cyclosporine

cyclosporine and Granulocytic Leukemia, Chronic

cyclosporine has been researched along with Granulocytic Leukemia, Chronic in 108 studies

Research

Studies (108)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's53 (49.07)18.2507
2000's40 (37.04)29.6817
2010's15 (13.89)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cardarelli, L; Chiaretti, S; Diverio, D; Foà, R; Giona, F; Mancini, F; Miano, M; Moleti, ML; Nanni, M; Palumbo, G; Peragine, N; Santopietro, M; Testi, AM; Zhang, K1
De Revel, T; Doghmi, K; Jennane, S; Konopacki, J; Mahtat, el M; Malfuson, JV; Mikdame, M1
Abkhiz, S; Eishei Oskuei, A; Farrokhpour, M; Makhdoomi, K; Vossoghian, S1
Baturin, D; Christians, U; DeGregori, J; Gardner, LA; Gore, L; Gregory, MA; Klawitter, J; Pollyea, DA; Porter, CC; Takebe, N; Zaberezhnyy, V1
Bao, JA; Ding, XL; Miao, LY; Xue, L; Zhang, JJ; Zhang, WW1
Adachi, S; Atsuta, Y; Azuma, E; Chin, M; Goto, H; Hatakeyama, N; Hyakuna, N; Igarashi, S; Inoue, M; Kato, K; Koh, K; Kudo, K; Murata, M; Ogawa, A; Ohshima, K; Sakata, N; Sawada, A; Takahashi, Y; Takami, A; Tanaka, S; Umeda, K1
Liu, H; Sun, Z; Tang, B; Wang, L; Yao, W; Zhang, L; Zheng, C; Zhu, X1
Andrews, LM; Atiq, F; Broers, AE; Doorduijn, JK; Koch, BC; Van Gelder, T; Versmissen, J2
Eskazan, AE1
Amat, P; Collado, M; Hernández-Boluda, JC; Marugán, I; Roda, D; Tormo, M1
Cho, GJ; Choi, YJ; Chung, JS; Kwon, BR; Seol, YM; Shin, HJ; Song, MK1
Honda, Y; Kashii, S; Manabe, S; Miki, Y1
Alvarez-Calderon, F; Degregori, J; Druker, BJ; Eide, CA; Gregory, MA; Neviani, P; O'Hare, T; Perrotti, D; Phang, TL; Williams, RT; Zaberezhnyy, V1
Cai, Z; Han, X; He, J; Huang, H; Li, L; Lin, M; Luo, Y; Shi, J; Tan, Y; Xie, W; Ye, X; Zhao, Y; Zheng, Y1
Andreoli, C; Barberi, W; Foà, R; Gualdi, G; Iori, AP; Mercanti, C; Natalino, F; Perrone, S; Torelli, GF; Valle, V1
da Cunha Vasconcelos, F; de Souza, PS; Maia, RC; Silva, LF1
Chen, L; Ding, X; Hou, J; Li, H; Lou, J; Min, B; Song, X; Tong, S; Wang, J; Zhang, W1
Appelbaum, FR; Dakhil, SR; Douer, D; Head, DR; Kopecky, KJ; List, AF; Slovak, ML; Willman, CL1
Hamaki, T; Kami, M; Kanda, Y; Kusumi, E; Mineishi, S; Miyakoshi, S; Momomura, S; Morinaga, S; Mutou, Y; Takaue, Y; Ueyama, J1
Aguilera, C; Boqué, C; Grañena, A; Petit, J; Vicente, L1
Korycka, A; Robak, T1
Fujimori, Y; Hara, H; Kakishita, E; Mori, A; Okada, M; Okamoto, T; Takatsuka, H; Wakae, T1
Chen, Y; Han, W; Hong, H; Huang, X; Lu, D1
Gardiner, N; Hayden, PJ; Lawler, M; McCann, SR; Molloy, K; Ryan, J1
Bergemann, T; Ehninger, G; Freiberg-Richter, J; Illmer, T; Oelschlägel, U; Platzbecker, U; Pursche, S; Schaich, M; Schleyer, E; von Bonin, M1
Kawauchi, K; Ogasawara, T; Ohkawa, S; Takei, K; Yasuyama, M1
Al-Ali, H; Brand, R; Deininger, M; Gentilini, C; Hegenbart, U; Krahl, R; Lange, T; Leiblein, S; Niederwieser, D; Petersdorf, E; Poenisch, W; Storb, RF; Uharek, L1
Choi, SJ; Kim, S; Kim, WK; Lee, JH; Lee, JS; Lee, KH; Lee, YS; Seol, M1
Fujiwara, T; Harigae, H; Ishizawa, K; Kameoka, J; Miyamura, K; Sasaki, T; Tomiya, Y; Yamada, M; Yokoyama, H1
Bullorsky, E; Ricchione, D; Saxton, R; Schamun, A; Stemmelin, G1
Furusyo, N; Hayashi, J; Henzan, H; Nakagawa, Y; Taniai, H; Tsuchihashi, T1
Fujimi, A; Iyama, S; Kawanishi, J; Kuribayashi, K; Matsunaga, T; Murase, K; Niitsu, Y; Sato, T; Takada, K; Takimoto, R1
Ashihara, E; Deguchi, Y; Hatake, K; Inui, K; Kamitsuji, Y; Kawata, E; Kimura, S; Kuroda, J; Maekawa, T; Masuda, S; Ruthardt, M; Sato, K; Terui, Y; Ueda, T; Urasaki, Y; Yokota, A1
Chen, SN; Fu, ZZ; Han, Y; He, GS; Jin, ZM; Ma, X; Miao, M; Qiu, HY; Sun, AN; Tang, XW; Wang, Y; Wu, DP; Xue, SL; Zhao, Y1
Jiang, ZX; Liu, LX; Sun, H; Sun, L; Wan, DM; Xie, XS1
Gao, CJ; Li, HH; Ning, CR; Yu, L1
Arai, S; Asai, T; Chiba, S; Hangaishi, A; Hosoya, N; Izutsu, K; Kanda, Y; Kurokawa, M; Motokura, T; Nakasone, H; Nishimoto, N; Oshima, K; Sato, H; Watanabe, T1
Arseniev, L; Bähre, O; Battmer, K; Berenson, RJ; Casper, J; Diedrich, H; Jacobs, R; Kadar, JG; Kühl, J; Link, H; Poliwoda, H; Schubert, J1
Baccarani, M; Baraldo, M; Damiani, D; Fanin, R; Furlanut, M; Michelutti, A; Michieli, M; Pea, F; Russo, D1
Berte, R; Buscarini, E; Buscarini, L; Cavanna, L; Civardi, G; Di Stasi, M; Fornari, F; Vallisa, D1
Gondo, H; Harada, M; Nakamura, M; Niho, Y; Okamura, S; Otsuka, T; Sano, T; Shimoda, K1
Beelen, DW; Liedtke, W; Quabeck, K; Schaefer, UW; Straeten, V1
FitzSimon, S; McCann, SR; O'Connor, M; O'Riordan, JM1
Aschan, J; Ringdén, O1
Amylon, MD; Chao, NJ; Long, GD; Nademanee, AP; Negrin, RS; O'Donnell, MR; Parker, PM; Smith, EP; Snyder, DS; Stein, AS1
Choudhury, S; Hait, WN; Murren, JR; Srimatkandada, S1
Angelucci, E; Baronciani, D; Erer, B; Galimberti, M; Gaziev, D; Giardini, C; Lucarelli, G; Polchi, P; Rapa, S; Ripalti, M1
Kumar, L1
Arcese, W; Bandini, G; Bosi, A; Carreras, E; Frassoni, F; Gahrton, G; Gratwohl, A; Hermans, J; Niederwieser, D; Vernant, JP1
Aschan, J; Klaesson, S; Ljungman, P; Lönnqvist, B; Ringdén, O; Sundberg, B1
Bafundi, P; Chan, CK; Fyles, G; Hyland, RH; Messner, H; Payne, L; Yeung, M1
Dörries, K; Schneider, EM1
Arranz, R; Fernández-Rañada, JM; Franceschi, JL; Yañez, E1
Belanger, R; Boileau, J; Bonny, Y; Kassis, J; Lacombe, M; Lalonde, Y; Lavallee, R; Perreault, C; Roy, DC; von Bueltzingsloewen, A1
Biggs, JC; Champlin, RE; Deeg, HJ; Dicke, K; Gale, RP; Horowitz, MM; Masaoka, T; Powles, RL; Ringdén, O; Sondel, P1
Arseniev, L; Bähre, O; Diedrich, H; Kadar, JG; Link, H; Poliwoda, H1
Baraldo, M; Cossettini, P; Furlanut, M; Pea, F; Wu, G1
Cervantes, F; Esteve, J; Marín, P; Montserrat, E; Rozman, C; Sanz, L; Vilardell, J1
Gerber, M; Gmeinhart, B; Greinix, H; Kalhs, P; Knobler, R; Volc-Platzer, B1
De'Arce, M; Gardiner, N; Lawler, M; McCann, SR; O'Riordan, J1
Batlle, M; Fernández-Avilés, F; Lauzurica, R; Ribera, JM1
Booth, M; Bull, A; Coleman, S; Evely, R; Lim, SH; O'Callaghan, U1
Kulkarni, S; Mehta, J; Powles, R; Singhal, S; Treleaven, J1
Fernández, CS; Gutiérrez, C; Herrera, P; López-Jiménez, J; Odriozola, J; Sánchez, A1
Iida, S; Kagami, Y; Miura, K; Morishima, Y; Nakamura, S; Ogura, M; Seto, M; Suzuki, R; Taji, H; Yatabe, Y1
Maia, RC; Noronha, H; Rumjanek, VM; Vasconcelos, FC1
Asano, S; Kikuchi, A; Nishikawa, T; Okamoto, S; Takahashi, S1
Amill, B; Berlanga, JJ; Boqué, C; Brunet, S; Canals, C; Cancelas, JA; Domingo-Albós, A; Ferra, C; Gallardo, D; García-López, J; Grañena, A; Martín-Henao, G; Martínez, C; Martino, R; Picón, M; Sureda, A; Torrico, C1
Beelen, DW; Elmaagacli, AH; Schaefer, UW1
Carriço, MK; Coelho, AM; Klumb, CE; Maia, RC; Noronha, H; Ruimanek, VM; Vasconcelos, FC1
Hirabayashi, N; Ikeda, Y; Ishida, A; Matsuoka, S; Moriki, T; Okamoto, S; Wakui, M; Watanabe, R1
Akan, H; Anadolu, R; Arat, M; Beksaç, M; Demirer, T; Dilek, I; Erdi, H; Ilhan, O; Koç, H; Ozcan, M; Ustün, C1
Budak-Alpdoğan, T; Kalayoğlu-Beşişik, S; Sargin, D; Tangün, Y1
Kamiya, Y; Kawahigashi, N; Kobayashi, Y; Maeda, A; Murayama, T; Nakata, M; Narabayashi, M; Sato, N; Takenaka, T; Takeyama, K; Tobinai, K; Togitani, K; Yokozawa, T1
Gorin, NC; Landman, J; Laporte, JP; Lesage, S; Najman, A; Portnoï, MF; Rubinstein, P1
Bordone, J; Etchegoyen, O; Milone, J; Morales, V; Napal, J1
Bradstock, K; Brandenburg, U; Gottlieb, D1
Hamaguchi, M; Haneda, M; Iida, H; Kanie, T; Kodera, Y; Minami, S; Murata, M; Nishida, T; Suzuki, R; Taji, H1
Drobyski, WR; Hessner, MJ; Kabler-Babbitt, C; Keever-Taylor, CA; Klein, JP; Margolis, DA; Vesole, DH1
Elgie, AW; Lewandowicz, GM; Sargent, JM; Taylor, CG; Williamson, CJ1
Biggs, JC; Gale, RP; Giralt, S; Goldman, JM; Herzig, RH; Horowitz, MM; Klein, JP; McGlave, PB; Rowlings, PA; Schiller, G; Szydlo, R; Veum-Stone, J1
Hibi, S; Imashuku, S; Misawa, A; Sawada, T; Takeuchi, Y; Todo, S1
Amylon, MD; Bluzme, KG; Chao, NJ; Forman, SJ; Fung, H; Hu, WW; Jain, M; Johnston, LJ; Kashyap, A; Kohler, S; Krishnan, A; Long, GD; Molina, A; Nademanee, AP; Negrin, RS; Niland, JC; O'Donnell, MR; Parker, P; Rodriguez, R; Snyder, DS; Spielberger, R; Stein, A; Stockerl-Goldstein, KE; Tierney, DK; Wong, RM1
Hasegawa, T; Hiraoka, A; Karasuno, T; Kawamoto, S; Masaoka, T; Murakami, M; Nakamura, H; Teshima, H; Uoshima, N; Yagi, T; Yasumi, M1
Bedrosian, I; Cohen, PA; Czerniecki, BJ; Engels, FH; Faries, MB; Koski, GK; Kreisel, D1
Attal, M; Blaise, D; Bordigoni, P; Buzyn, A; Fegueux, N; Garban, F; Gluckman, E; Guardiola, P; Kuentz, M; Lioure, B; Reiffers, J; Socié, G; Tanguy, ML; Vernant, JP1
Ikegawa, T; Koyabu, N; Morimoto, S; Naito, M; Ohtani, H; Sawada, Y; Shoyama, Y; Tsuruo, T; Ushigome, F1
Baron, F; Beguin, Y; Fillet, G; Gothot, A; Hermanne, JP; Pierard, GE; Salmon, JP1
Boruczkowski, D; Jólkowska, J; Ladon, D; Leda, M; Pieczonka, A; Wachowiak, J; Witt, M1
Casey, SO; Michel, E; Teksam, M; Truwit, CL1
Durrant, S; Irving, I; Mollee, P; Morton, AJ1
Lynch, P; Magariños, G; Marini, M; Remorino, L; Saponaro, A1
Appelbaum, FR; Bensinger, WI; Blume, KG; Bryant, E; Chauncey, TR; Flowers, ME; Georges, GE; Gooley, TA; Grumet, FC; Hegenbart, U; Kiem, HP; Maloney, DG; McSweeney, PA; Minor, S; Molina, AJ; Nash, RA; Niederwieser, D; Radich, J; Sandmaier, BM; Shizuru, JA; Storb, RF; Torok-Storb, B; Wagner, JL; Yu, C1
Battmer, K; Dammann, E; Eder, M; Ganser, A; Hambach, L; Heil, G; Hertenstein, B; Stucki, A1
Ait Arkoub, Z; Arnulf, B; Chebbi, F; Fillet, AM; Lefrere, F; Varet, B1
Zelunka, EJ1
Döhner, H; Gabler, A; Haas, R; Hartmann, F; Hensel, M; Ho, AD; Jung, W; Schlenk, RF; Trümper, L; Weber-Nordt, R1
Akan, H; Beksaç, M; Ertürk, S; Güneyli, A; Ikizünal, Y; Ilhan, O; Koç, H; Sardaş, OS1
Apperley, J; Barrett, AJ; Cullis, JO; Hows, JM; Hughes, TP; Kelly, S; Mackinnon, S; Marks, DI; Schwarer, AP; Szydlo, R1
Chiba, S; Fujita, S; Kamimura, S; Katoh, S; Kudoh, T; Miura, J; Sakuma, Y; Suzuki, N; Yohtoh, Y1
Beelen, DW; Brandt, H; Graeven, U; Haralambie, E; Linzenmeier, G; Mahmoud, HK; Müller, KD; Quabeck, K; Sayer, HG; Schaefer, UW1
Cámara, R; Fernández-Villalta, MJ; Ferro, T; Figuera, A; Kassack, JJ; Lamana, M; López, J; Serrano, F; Steegmann, JL; Vázquez, L1
Bennett, M; Collins, RH; Fay, JW; Kumar, V; Nikein, A; Rogers, ZR1
Barbara, JA; Gillis, D; Ho, JO; Smith, PS; Thomas, AC; Woodroffe, AJ1
Goldman, JM1
Anasetti, C; Appelbaum, FR; Bensinger, W; Buckner, CD; Cliff, RA; Deeg, HJ; Doney, K; Hansen, J; Pepe, M; Storb, R1
Hidaka, S; Hiraoka, A; Kobayashi, M; Matsunashi, T; Nakamura, H; Tejima, H; Tominaga, N; Yoshida, H; Yoshida, S; Yoshimura, M1

Reviews

3 review(s) available for cyclosporine and Granulocytic Leukemia, Chronic

ArticleYear
Chronic myeloid leukemia: management of relapse after allogeneic bone marrow transplantation.
    Leukemia & lymphoma, 1993, Volume: 10, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Clinical Trials as Topic; Cyclosporine; Graft Enhancement, Immunologic; Graft vs Host Disease; Humans; Hydroxyurea; Immunologic Factors; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Remission Induction; Reoperation; Risk Factors; Salvage Therapy; Survival Rate; Treatment Outcome

1993
Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia.
    Bone marrow transplantation, 2001, Volume: 28, Issue:7

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Bone Marrow Transplantation; Combined Modality Therapy; Cyclosporine; Cystitis; Cytarabine; Cytomegalovirus Infections; DNA, Neoplasm; Female; Foscarnet; Ganciclovir; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Histocompatibility; Humans; Hydroxyurea; Immunosuppressive Agents; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Mitoxantrone; Neoplasms, Second Primary; Prednisolone; Prostaglandins; Remission Induction; Topotecan; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation

2001
Bone marrow transplantation for chronic myeloid leukaemia.
    Leukemia, 1992, Volume: 6 Suppl 2

    Topics: Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Histocompatibility; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Accelerated Phase; Leukemia, Myeloid, Chronic-Phase; Methotrexate; Recurrence; Time Factors; Transplantation, Homologous

1992

Trials

16 trial(s) available for cyclosporine and Granulocytic Leukemia, Chronic

ArticleYear
Inhibition of calcineurin combined with dasatinib has direct and indirect anti-leukemia effects against BCR-ABL1(+) leukemia.
    American journal of hematology, 2014, Volume: 89, Issue:9

    Topics: Adult; Animals; Antineoplastic Combined Chemotherapy Protocols; Calcineurin Inhibitors; Cell Line, Tumor; Cyclosporine; Dasatinib; Drug Synergism; Female; Flow Cytometry; Fusion Proteins, bcr-abl; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Mice; Mice, Inbred C57BL; Middle Aged; Protein Kinase Inhibitors; Pyrimidines; Thiazoles; Treatment Outcome

2014
Cyclosporine inhibition of P-glycoprotein in chronic myeloid leukemia blast phase.
    Blood, 2002, Sep-01, Volume: 100, Issue:5

    Topics: Adult; Aged; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporine; Female; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Prognosis; Remission Induction

2002
Cyclosporine alone vs cyclosporine plus methotrexate for post-transplant immunosuppression after HLA-identical sibling bone marrow transplantation: a randomized prospective study.
    Bone marrow transplantation, 2004, Volume: 34, Issue:7

    Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; HLA Antigens; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Prospective Studies; Recurrence; Siblings; Survival Rate; Tissue Donors

2004
[Peripheral blood stem cell transplantation for 53 patients with malignant hematologic diseases].
    Ai zheng = Aizheng = Chinese journal of cancer, 2007, Volume: 26, Issue:4

    Topics: Adolescent; Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclosporine; Disease-Free Survival; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Peripheral Blood Stem Cell Transplantation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transplantation Conditioning; Transplantation, Homologous; Young Adult

2007
Combined transplantation of allogeneic bone marrow and CD34+ blood cells.
    Blood, 1995, Oct-01, Volume: 86, Issue:7

    Topics: Adult; Antigens, CD; Antigens, CD34; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Whole-Body Irradiation

1995
Fractionated total-body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 94 patients with chronic myelogenous leukemia in chronic phase.
    Blood, 1994, Sep-01, Volume: 84, Issue:5

    Topics: Adolescent; Adult; Bone Marrow Transplantation; Cause of Death; Child; Chromosome Aberrations; Chromosome Disorders; Cyclosporine; Cytogenetics; Drug Therapy, Combination; Etoposide; Female; Graft vs Host Disease; Humans; Immunosuppression Therapy; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Methylprednisolone; Middle Aged; Recurrence; Survival Rate; Whole-Body Irradiation

1994
Allogeneic marrow transplantation in patients with chronic myeloid leukemia in chronic phase following preparation with busulfan and cyclophosphamide.
    Bone marrow transplantation, 1994, Volume: 13, Issue:2

    Topics: Adolescent; Adult; Bone Marrow Transplantation; Busulfan; Child; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Dose-Response Relationship, Drug; Female; Graft vs Host Disease; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Middle Aged; Prednisolone; Transplantation, Homologous

1994
Transplantation of allogeneic CD34+ blood cells.
    Blood, 1996, Jun-01, Volume: 87, Issue:11

    Topics: Acute Disease; Adult; Antigens, CD34; Bone Marrow; Cell Division; Cyclosporine; Erythropoietin; Female; Filgrastim; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Immunosuppressive Agents; Leukapheresis; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Male; Methotrexate; Middle Aged; Platelet Transfusion; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Recombinant Proteins; T-Lymphocytes; Transplantation, Homologous

1996
Donor chimaerism is a strong indicator of disease free survival following bone marrow transplantation for chronic myeloid leukaemia.
    Leukemia, 1997, Volume: 11 Suppl 3

    Topics: Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Female; Follow-Up Studies; Fusion Proteins, bcr-abl; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphocyte Depletion; Male; Methotrexate; Middle Aged; Polymerase Chain Reaction; Prognosis; T-Lymphocytes; Time Factors; Transcription, Genetic; Transplantation Chimera

1997
Induction of graft-versus-host disease as immunotherapy of leukemia relapsing after allogeneic transplantation: single-center experience of 32 adult patients.
    Bone marrow transplantation, 1997, Volume: 20, Issue:2

    Topics: Acute Disease; Adolescent; Adult; Antineoplastic Agents; Bone Marrow Transplantation; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunotherapy, Adoptive; Interferon alpha-2; Interferon-alpha; Interleukin-2; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Lymphoid; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Leukocytes; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recombinant Proteins; Recurrence; Remission Induction

1997
Unrelated mismatched cord blood transplantation in patients with hematological malignancies: a single institution experience.
    Bone marrow transplantation, 1998, Volume: 22 Suppl 1

    Topics: Adolescent; Adrenal Cortex Hormones; Adult; Burkitt Lymphoma; Cyclosporine; Erythropoietin; Female; Fetal Blood; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male

1998
Equivalence of 2 effective graft-versus-host disease prophylaxis regimens: results of a prospective double-blind randomized trial.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2000, Volume: 6, Issue:3

    Topics: Acute Disease; Adolescent; Adult; Anti-Inflammatory Agents; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Double-Blind Method; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infant; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Methotrexate; Middle Aged; Prednisone; Prospective Studies; Survival Analysis; Transplantation, Homologous; Treatment Outcome

2000
Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects.
    Blood, 2001, Jun-01, Volume: 97, Issue:11

    Topics: Adult; Aged; Aging; Cause of Death; Cyclosporine; Female; Graft Rejection; Graft vs Tumor Effect; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Leukocyte Count; Male; Middle Aged; Multiple Myeloma; Mycophenolic Acid; Neutrophils; Platelet Count; Remission Induction; Survival Rate; T-Lymphocytes; Transplantation Conditioning; Whole-Body Irradiation

2001
Less intense conditioning with fludarabine, cyclophosphamide, idarubicin and etoposide (FCIE) followed by allogeneic unselected peripheral blood stem cell transplantation in elderly patients with leukemia.
    Leukemia, 2002, Volume: 16, Issue:4

    Topics: Adult; Aged; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Etoposide; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Chronic-Phase; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Survival Rate; Transplantation Conditioning; Transplantation, Homologous; Vidarabine

2002
Fractionated TBI and methotrexate-cyclosporin do not seem to increase relapses in BMT for first chronic phase CML patients: results of a single centre study.
    Bone marrow transplantation, 1992, Volume: 10, Issue:3

    Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Chronic-Phase; Male; Methotrexate; Pulmonary Fibrosis; Recurrence; Whole-Body Irradiation

1992
Long-term follow-up of a controlled trial comparing a combination of methotrexate plus cyclosporine with cyclosporine alone for prophylaxis of graft-versus-host disease in patients administered HLA-identical marrow grafts for leukemia.
    Blood, 1992, Jul-15, Volume: 80, Issue:2

    Topics: Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Graft vs Host Disease; Histocompatibility Testing; HLA Antigens; Humans; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Methotrexate; Time Factors

1992

Other Studies

89 other study(ies) available for cyclosporine and Granulocytic Leukemia, Chronic

ArticleYear
Atypical Chronic Myeloid Leukemia in a Patient with Aplastic Anemia.
    Acta haematologica, 2019, Volume: 142, Issue:3

    Topics: Adolescent; Anemia, Aplastic; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Cytarabine; Etoposide; Fatal Outcome; Granulocyte Colony-Stimulating Factor; Humans; Imidazoles; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methylprednisolone; Prednisolone; Pyridazines

2019
Cyclosporine-related posterior reversible encephalopathy syndrome after cord blood stem cell transplantation.
    Hematology/oncology and stem cell therapy, 2013, Volume: 6, Issue:2

    Topics: Adolescent; Antineoplastic Agents; Cord Blood Stem Cell Transplantation; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Magnetic Resonance Imaging; Posterior Leukoencephalopathy Syndrome; Radiography; Vidarabine; Whole-Body Irradiation

2013
Successful treatment of Chronic Myelogenic Leukemia (CML) with imatinib after renal transplantation.
    Archives of Iranian medicine, 2014, Volume: 17, Issue:5

    Topics: Antineoplastic Agents; Benzamides; Cyclosporine; Humans; Imatinib Mesylate; Immunosuppressive Agents; Kidney Transplantation; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Piperazines; Prednisolone; Pyrimidines

2014
Population pharmacokinetics and individualized dosage prediction of cyclosporine in allogeneic hematopoietic stem cell transplant patients.
    The American journal of the medical sciences, 2014, Volume: 348, Issue:6

    Topics: Adult; Anemia, Aplastic; ATP Binding Cassette Transporter, Subfamily B; Cohort Studies; Cyclosporine; Cytochrome P-450 CYP3A; Female; Graft Rejection; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Models, Biological; Myelodysplastic Syndromes; Polymorphism, Genetic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transplantation, Homologous

2014
Comparison of continuous and twice-daily infusions of cyclosporine A for graft-versus-host-disease prophylaxis in pediatric hematopoietic stem cell transplantation.
    Pediatric blood & cancer, 2015, Volume: 62, Issue:2

    Topics: Adolescent; Child; Child, Preschool; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Retrospective Studies; Surveys and Questionnaires; Treatment Outcome

2015
[Allo-geneic hematopoietic stem cell transplantation in treatment with T315I mutation of chronic myelogenous leukemia].
    Zhonghua yi xue za zhi, 2014, Nov-04, Volume: 94, Issue:40

    Topics: Adult; Allografts; Benzamides; Cord Blood Stem Cell Transplantation; Cyclosporine; Disease-Free Survival; Female; Fusion Proteins, bcr-abl; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Mutation; Mycophenolic Acid; Peripheral Blood Stem Cell Transplantation; Piperazines; Pyrimidines; Retrospective Studies; Siblings

2014
A clinically relevant pharmacokinetic interaction between cyclosporine and imatinib.
    European journal of clinical pharmacology, 2016, Volume: 72, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Drug Interactions; Female; Hematopoietic Stem Cell Transplantation; Humans; Imatinib Mesylate; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Protein Kinase Inhibitors; Young Adult

2016
Co-administration of cyclosporine A and imatinib among patients with Philadelphia chromosome-positive leukemias in the post-transplant setting.
    European journal of clinical pharmacology, 2016, Volume: 72, Issue:12

    Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporine; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Therapy, Combination; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Imatinib Mesylate; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Philadelphia Chromosome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors

2016
Response: Co-administration of cyclosporine A and imatinib among patients with Philadelphia chromosome-positive leukemias in the post-transplant setting.
    European journal of clinical pharmacology, 2016, Volume: 72, Issue:12

    Topics: Antineoplastic Agents; Benzamides; Cyclosporine; Humans; Imatinib Mesylate; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Philadelphia Chromosome; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines

2016
Sustained complete molecular remission after imatinib discontinuation due to severe aplastic anemia.
    Leukemia research, 2009, Volume: 33, Issue:4

    Topics: Aged; Analgesics, Non-Narcotic; Anemia, Aplastic; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Agents; Benzamides; Cyclosporine; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Mycoses; Piperazines; Pyrimidines; Remission Induction; Respiratory Tract Infections

2009
Influence of lactate dehydrogenase and cyclosporine A level on the incidence of acute graft-versus-host disease after allogeneic stem cell transplantation.
    Journal of Korean medical science, 2009, Volume: 24, Issue:4

    Topics: Acute Disease; Adult; Cyclosporine; Female; Graft vs Host Disease; Humans; L-Lactate Dehydrogenase; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Retrospective Studies; Risk Factors; Stem Cell Transplantation; Transplantation, Homologous

2009
Analysis of cyclosporin A-induced reversible cortical blindness by diffusion-weighted magnetic resonance imaging techniques.
    Japanese journal of ophthalmology, 2010, Volume: 54, Issue:3

    Topics: Blindness, Cortical; Bone Marrow Transplantation; Cyclosporine; Diffusion Magnetic Resonance Imaging; Female; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Young Adult

2010
Wnt/Ca2+/NFAT signaling maintains survival of Ph+ leukemia cells upon inhibition of Bcr-Abl.
    Cancer cell, 2010, Jul-13, Volume: 18, Issue:1

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Blotting, Western; Calcium; Cell Proliferation; Cyclosporine; Cytokines; Dasatinib; Female; Flow Cytometry; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Mice, Inbred C57BL; NFATC Transcription Factors; Philadelphia Chromosome; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Signal Transduction; Thiazoles; Tumor Cells, Cultured; Wnt Proteins

2010
Imatinib combined with myeloablative allogeneic hematopoietic stem cell transplantation for advanced phases of chronic myeloid leukemia.
    Leukemia research, 2011, Volume: 35, Issue:10

    Topics: Adult; Benzamides; Blast Crisis; Busulfan; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Disease Progression; Female; Follow-Up Studies; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Myeloablative Agonists; Piperazines; Pyrimidines; Remission Induction; Survival Rate; Transplantation Conditioning; Transplantation, Homologous

2011
Early onset of posterior reversible encephalopathy syndrome (PRES) during Cyclosporine-A infusion.
    Leukemia research, 2011, Volume: 35, Issue:10

    Topics: Adult; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infusions, Intravenous; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Magnetic Resonance Imaging; Male; Myeloablative Agonists; Posterior Leukoencephalopathy Syndrome; Transplantation Conditioning; Transplantation, Homologous

2011
Cyclosporine A enables vincristine-induced apoptosis during reversal of multidrug resistance phenotype in chronic myeloid leukemia cells.
    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2012, Volume: 33, Issue:4

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Caspase 3; Cell Cycle; Cell Line, Tumor; Cell Survival; Cyclosporine; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Flow Cytometry; Humans; Immunosuppressive Agents; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Vincristine; X-Linked Inhibitor of Apoptosis Protein

2012
[Combination of mycophenolate mofetil with cyclosporine A and methotrexate for the prophylaxes of acute graft versus host disease in allogeneic peripheral stem cell transplantation].
    Zhonghua yi xue za zhi, 2002, Apr-25, Volume: 82, Issue:8

    Topics: Acute Disease; Adult; Anemia, Aplastic; Blood Platelets; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Male; Methotrexate; Middle Aged; Mouth Mucosa; Mycophenolic Acid; Neutrophils; Transplantation, Homologous; Treatment Outcome

2002
Sustained molecular remission in a patient with CML in blastic crisis receiving dose-reduced hematopoietic stem-cell transplantation followed by early withdrawal of cyclosporine and prophylactic use of interferon-alpha.
    American journal of hematology, 2002, Volume: 71, Issue:3

    Topics: Blast Crisis; Cyclosporine; Drug Administration Schedule; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Neoplasm Recurrence, Local; Remission Induction

2002
Central and extrapontine myelinolysis following allogeneic peripheral haematopoietic progenitor cell transplantation. Favourable outcome in a patient with chronic myeloid leukaemia.
    Bone marrow transplantation, 2003, Volume: 31, Issue:1

    Topics: Brain; Central Nervous System Diseases; Cyclosporine; Graft vs Host Disease; Humans; Immunosuppressive Agents; In Vitro Techniques; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Magnetic Resonance Imaging; Male; Stem Cell Transplantation; Treatment Outcome

2003
The effect of cyclosporin A used alone and in combination with either 2-chlorodeoxyadenosine or fludarabine on normal and chronic myelogenous leukemia progenitors in vitro.
    Archivum immunologiae et therapiae experimentalis, 2003, Volume: 51, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Colony-Forming Units Assay; Cyclosporine; Enzyme Inhibitors; Hematopoietic Stem Cells; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Middle Aged; Vidarabine

2003
Prognostic value of cyclic GMP in patients undergoing allogeneic bone marrow transplantation after conditioning with total body irradiation.
    Bone marrow transplantation, 2003, Volume: 31, Issue:10

    Topics: Adolescent; Adult; Biomarkers; Blast Crisis; Bone Marrow Transplantation; Cyclic GMP; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Methylprednisolone; Monitoring, Physiologic; Myelodysplastic Syndromes; Neoplasm Staging; Nitric Oxide; Prognosis; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Whole-Body Irradiation

2003
[Human leukocyte antigen mismatched hemopietic stem cell transplants for the treatment of leukemia].
    Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences, 2003, Apr-18, Volume: 35, Issue:2

    Topics: Bone Marrow Transplantation; Cyclophosphamide; Cyclosporine; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Histocompatibility Antigens Class II; HLA Antigens; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Methotrexate; Mycophenolic Acid; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Homologous

2003
Pure red cell aplasia after a major ABO-mismatched bone marrow transplant for chronic myeloid leukaemia: response to re-introduction of cyclosporin.
    Bone marrow transplantation, 2004, Volume: 33, Issue:4

    Topics: ABO Blood-Group System; Blood Group Incompatibility; Bone Marrow Transplantation; Cyclosporine; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Middle Aged; Red-Cell Aplasia, Pure

2004
P-glycoprotein-mediated drug efflux is a resistance mechanism of chronic myelogenous leukemia cells to treatment with imatinib mesylate.
    Leukemia, 2004, Volume: 18, Issue:3

    Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzamides; Cell Division; Cyclosporine; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Enzyme Inhibitors; Fusion Proteins, bcr-abl; Gene Expression Regulation, Leukemic; Humans; Imatinib Mesylate; Immunosuppressive Agents; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Nuclear Proteins; Piperazines; Pyrimidines; Rhodamines

2004
[Pure red cell aplasia occurring during the course of chronic myelogenous leukemia].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2004, Volume: 45, Issue:1

    Topics: Acute Disease; Antineoplastic Agents; Blood Transfusion; Cyclosporine; Hepatitis C; Humans; Hydroxyurea; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Red-Cell Aplasia, Pure

2004
BCR-ABL transcripts are early predictors for hematological relapse in chronic myeloid leukemia after hematopoietic cell transplantation with reduced intensity conditioning.
    Leukemia, 2004, Volume: 18, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclosporine; Female; Fusion Proteins, bcr-abl; Hematopoietic Stem Cell Transplantation; Hematopoietic System; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Mycophenolic Acid; Neoplasm Recurrence, Local; Prognosis; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; Sensitivity and Specificity; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation

2004
Imatinib mesylate in conjunction with allogeneic hematopoietic stem cell transplantation in patients with Philadelphia chromosome positive leukemias: report of 4 cases.
    The Tohoku journal of experimental medicine, 2004, Volume: 204, Issue:1

    Topics: Adult; Antineoplastic Agents; Benzamides; Cyclosporine; Enzyme Inhibitors; Female; Hematopoietic Stem Cell Transplantation; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Piperazines; Pyrimidines; Transplantation, Homologous; Treatment Outcome

2004
Treatment with cyclosporin A cream for the cutaneous reactions associated with imatinib therapy.
    Blood, 2005, Apr-01, Volume: 105, Issue:7

    Topics: Administration, Topical; Antineoplastic Agents; Benzamides; Cyclosporine; Drug Hypersensitivity; Female; Humans; Imatinib Mesylate; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Male; Middle Aged; Piperazines; Pyrimidines

2005
Chronic myelogenous leukemia that occurred two years after the diagnosis of adult Still's disease.
    Internal medicine (Tokyo, Japan), 2005, Volume: 44, Issue:9

    Topics: Adult; Cyclosporine; Drug Resistance; Genes, abl; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Steroids; Still's Disease, Adult-Onset; Time Factors

2005
Human herpesvirus-6 hepatitis associated with cyclosporine-A encephalitis after bone marrow transplantation for chronic myeloid leukemia.
    Internal medicine (Tokyo, Japan), 2006, Volume: 45, Issue:7

    Topics: Adult; Bone Marrow Transplantation; Brain; Cyclosporine; Encephalitis; Graft vs Host Disease; Hepatitis, Viral, Human; Herpesviridae Infections; Herpesvirus 6, Human; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Liver; Magnetic Resonance Imaging; Male

2006
INNO-406, a novel BCR-ABL/Lyn dual tyrosine kinase inhibitor, suppresses the growth of Ph+ leukemia cells in the central nervous system, and cyclosporine A augments its in vivo activity.
    Blood, 2007, Jan-01, Volume: 109, Issue:1

    Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzamides; Brain; Cyclosporine; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Injections; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Mice; Mice, Inbred BALB C; Mice, Inbred NOD; Mice, Nude; Mice, SCID; Neoplasm Proteins; Neoplasm Transplantation; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-abl; Pyrimidines; Random Allocation; src-Family Kinases

2007
[Clinical study on haploid HLA-matched hematopoietic stem cell transplantation for treatment of malignant hematological disease].
    Ai zheng = Aizheng = Chinese journal of cancer, 2006, Volume: 25, Issue:8

    Topics: Adolescent; Adult; Antibodies, Monoclonal; Antilymphocyte Serum; Basiliximab; Bone Marrow Transplantation; Child; Cyclosporine; Disease-Free Survival; Female; Follow-Up Studies; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Haploidy; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Histocompatibility; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recombinant Fusion Proteins; Survival Rate; Transplantation Conditioning; Young Adult

2006
[Reversing of donor chimeras by stopping use of CsA in 2 CML patients relapsed after transplantation].
    Zhongguo shi yan xue ye xue za zhi, 2007, Volume: 15, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Graft vs Leukemia Effect; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Neoplasm Recurrence, Local; Peripheral Blood Stem Cell Transplantation; Transplantation Chimera

2007
Decreased incidence of acute graft-versus-host disease by continuous infusion of cyclosporine with a higher target blood level.
    American journal of hematology, 2008, Volume: 83, Issue:3

    Topics: Acute Disease; Adult; Antineoplastic Agents; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Incidence; Infusions, Intravenous; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Living Donors; Male; Methotrexate; Middle Aged; Transplantation, Homologous; Whole-Body Irradiation

2008
P170-related multidrug resistance. Enhancement of idarubicin content in leukemic cells with cyclosporin in vivo: a report of two cases.
    Leukemia, 1995, Volume: 9, Issue:10

    Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporine; Drug Resistance, Multiple; Humans; Idarubicin; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukocyte Count; Male; Middle Aged

1995
Severe immune thrombocytopenic purpura relapse after alpha-interferon in chronic myeloid leukemia, successfully treated with cyclosporine.
    American journal of hematology, 1994, Volume: 47, Issue:3

    Topics: Cyclosporine; Female; Humans; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Middle Aged; Purpura, Thrombocytopenic, Idiopathic; Recurrence

1994
Myasthenia gravis after allogeneic bone marrow transplantation.
    Bone marrow transplantation, 1994, Volume: 14, Issue:1

    Topics: Adult; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Graft vs Host Disease; HLA-B7 Antigen; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Myasthenia Gravis; Prednisolone; Transplantation, Homologous

1994
Recurrent acute inflammatory demyelinating polyradiculitis after allogeneic bone marrow transplantation.
    Journal of the neurological sciences, 1994, Volume: 125, Issue:1

    Topics: Acute Disease; Adult; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Demyelinating Diseases; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Polyradiculopathy; Prednisone; Recurrence; Transplantation, Homologous

1994
Retinal microvascular changes following bone marrow transplantation: the role of cyclosporine.
    Bone marrow transplantation, 1994, Volume: 13, Issue:1

    Topics: Adolescent; Adult; Bone Marrow Transplantation; Busulfan; Combined Modality Therapy; Cyclosporine; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Microcirculation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retinal Vessels

1994
Prognostic factors for long-term survival in leukemic marrow recipients with special emphasis on age and prophylaxis for graft-versus-host disease.
    Clinical transplantation, 1994, Volume: 8, Issue:3 Pt 1

    Topics: Adolescent; Adult; Age Factors; Aged; Bone Marrow Transplantation; Cause of Death; Child; Child, Preschool; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Infant; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Retrospective Studies; Risk Factors; Survival Rate

1994
Sensitivity of K562 human chronic myelogenous leukemia blast cells transfected with a human multidrug resistance cDNA to cytotoxic drugs and differentiating agents.
    The Journal of clinical investigation, 1993, Volume: 91, Issue:5

    Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Southern; Cell Differentiation; Cyclosporine; Cytarabine; DNA; Drug Resistance; Flupenthixol; Gene Expression; Hemin; Humans; Kinetics; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Membrane Glycoproteins; RNA, Messenger; Transfection; Tumor Cells, Cultured; Vinblastine

1993
Bone marrow transplantation for chronic myeloid leukemia: long-term results. Chronic Leukemia Working Party of the European Group for Bone Marrow Transplantation.
    Bone marrow transplantation, 1993, Volume: 12, Issue:5

    Topics: Adult; Age Factors; Bone Marrow Transplantation; Cohort Studies; Cyclosporine; Family Health; Female; Graft vs Host Disease; HLA Antigens; Humans; Incidence; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphocyte Depletion; Male; Methotrexate; Middle Aged; Multivariate Analysis; Prognosis; Recurrence; Retrospective Studies; Surveys and Questionnaires; Survival Rate; Time Factors; Tissue Donors

1993
Increased risk of relapse in patients with chronic myelogenous leukemia given T-cell depleted marrow compared to methotrexate combined with cyclosporin or monotherapy for the prevention of graft-versus-host disease.
    European journal of haematology, 1993, Volume: 50, Issue:5

    Topics: Adolescent; Adult; Bone Marrow Cells; Bone Marrow Transplantation; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunosuppression Therapy; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphocyte Depletion; Male; Methotrexate; Middle Aged; Retrospective Studies

1993
Cyclosporine as possible prophylaxis for obstructive airways disease after allogeneic bone marrow transplantation.
    Chest, 1993, Volume: 104, Issue:1

    Topics: Adolescent; Adult; Bone Marrow Transplantation; Cohort Studies; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Lung Diseases, Obstructive; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Prospective Studies; Respiratory Function Tests; Retrospective Studies; Risk Factors; Transplantation, Homologous

1993
High frequency of polyomavirus infection in lymphoid cell preparations after allogeneic bone marrow transplantation.
    Transplantation proceedings, 1993, Volume: 25, Issue:1 Pt 2

    Topics: Adult; Base Sequence; Bone Marrow; Bone Marrow Transplantation; Cyclosporine; DNA, Viral; Graft vs Host Disease; Humans; JC Virus; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Lymphocytes; Male; Molecular Sequence Data; Oligodeoxyribonucleotides; Polymerase Chain Reaction; Precursor Cell Lymphoblastic Leukemia-Lymphoma; RNA Probes; Transplantation, Homologous; Tumor Virus Infections

1993
More about omeprazole-cyclosporine interaction.
    The American journal of gastroenterology, 1993, Volume: 88, Issue:1

    Topics: Adult; Cyclosporine; Drug Interactions; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Liver; Omeprazole

1993
Acute graft-versus-host disease prophylaxis with methotrexate and cyclosporine after busulfan and cyclophosphamide in patients with hematologic malignancies.
    Blood, 1993, Feb-01, Volume: 81, Issue:3

    Topics: Adult; Busulfan; Chronic Disease; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Incidence; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Time Factors

1993
Methotrexate, cyclosporine, or both to prevent graft-versus-host disease after HLA-identical sibling bone marrow transplants for early leukemia?
    Blood, 1993, Feb-15, Volume: 81, Issue:4

    Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host Disease; Histocompatibility; Humans; Infant; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma

1993
Effects of different sampling strategies on predictions of blood cyclosporine concentrations in haematological patients with multidrug resistance by Bayesian and non-linear least squares methods.
    Pharmacological research, 1995, Volume: 32, Issue:6

    Topics: Adult; Aged; Bayes Theorem; Cyclosporine; Drug Resistance, Multiple; Female; Hematologic Diseases; Humans; Least-Squares Analysis; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma

1995
[Chronic myeloid leukemia after renal transplantation: report of a new case and review of the bibliography].
    Sangre, 1996, Volume: 41, Issue:5

    Topics: Adult; Azathioprine; Cyclosporine; Female; Humans; Hydroxyurea; Immunosuppressive Agents; Incidence; Kidney Transplantation; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Postoperative Complications

1996
Complete remission of lichen-planus-like graft-versus-host disease (GVHD) with extracorporeal photochemotherapy (ECP).
    Bone marrow transplantation, 1997, Volume: 19, Issue:5

    Topics: Acute Disease; Bone Marrow Transplantation; Cyclosporine; Extracorporeal Circulation; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lichen Planus; Male; Middle Aged; Prednisolone; PUVA Therapy; Remission Induction; Skin Diseases; Transplantation, Homologous

1997
[Chronic myeloid leukemia after kidney transplantation].
    Sangre, 1997, Volume: 42, Issue:1

    Topics: Adult; Cyclosporine; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Chronic-Phase; Male; Postoperative Complications

1997
Cyclosporin A/alpha interferon-induced autologous graft-versus-host disease following peripheral blood stem cell transplant for chronic myeloid leukaemia: a clinico-pathological study.
    Bone marrow transplantation, 1997, Volume: 20, Issue:1

    Topics: Antineoplastic Agents; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Transplantation, Autologous

1997
Cyclosporine-induced retinal toxic blindness.
    Bone marrow transplantation, 1997, Volume: 20, Issue:3

    Topics: Adult; Blindness; Bone Marrow Transplantation; Cyclosporine; Female; Graft Rejection; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Retina; Transplantation, Homologous

1997
Complete cytogenetic response with host-derived hematopoiesis induced by cyclosporin A discontinuation in a patient with relapsed chronic myelogenous leukemia after bone marrow transplantation.
    Bone marrow transplantation, 1997, Volume: 20, Issue:7

    Topics: Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Female; Hematopoiesis; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Middle Aged; Recurrence; Transplantation, Homologous

1997
Interaction of cyclosporin A and etoposide. Clinical and in vitro assessment in blast phase of chronic myeloid leukaemia.
    Clinical and laboratory haematology, 1997, Volume: 19, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Cyclosporine; Drug Interactions; Etoposide; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male

1997
Linear chronic cutaneous graft-versus-host disease.
    Journal of the American Academy of Dermatology, 1997, Volume: 37, Issue:6

    Topics: Adult; Basement Membrane; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Cytarabine; E-Selectin; Epidermis; Graft vs Host Disease; Humans; Immunosuppressive Agents; Intercellular Adhesion Molecule-1; Keratosis; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lichenoid Eruptions; Male; Methotrexate; Platelet Endothelial Cell Adhesion Molecule-1; Transplantation, Homologous; Whole-Body Irradiation

1997
Low-dose donor CD8+ cells in the CD4-depleted graft prevent allogeneic marrow graft rejection and severe graft-versus-host disease for chronic myeloid leukemia patients in first chronic phase.
    Bone marrow transplantation, 1997, Volume: 20, Issue:11

    Topics: Adult; Bone Marrow Cells; Bone Marrow Transplantation; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cyclosporine; Female; Flow Cytometry; Graft Rejection; Graft vs Host Disease; Humans; Immunoglobulins, Intravenous; Immunomagnetic Separation; Immunophenotyping; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Middle Aged; Pilot Projects; T-Lymphocyte Subsets; Transplantation Conditioning; Transplantation, Homologous

1997
A retrospective single centre study of the outcome of five different therapy approaches in 48 patients with relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation.
    Bone marrow transplantation, 1997, Volume: 20, Issue:12

    Topics: Adolescent; Adult; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Blast Crisis; Bone Marrow Transplantation; Combined Modality Therapy; Cyclosporine; Disease Management; Disease-Free Survival; Female; Fusion Proteins, bcr-abl; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Factors; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Accelerated Phase; Leukocyte Transfusion; Male; Middle Aged; Neoplasm, Residual; Polymerase Chain Reaction; Recombinant Proteins; Recurrence; Remission Induction; Retrospective Studies; RNA, Messenger; RNA, Neoplasm; Salvage Therapy; Survival Analysis; Treatment Outcome

1997
Clinical approach to circumvention of multidrug resistance in refractory leukemic patients: association of cyclosporin A with etoposide.
    Journal of experimental & clinical cancer research : CR, 1997, Volume: 16, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blast Crisis; Child; Cyclosporine; Drug Resistance, Multiple; Etoposide; Female; Growth Inhibitors; Humans; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tumor Cells, Cultured

1997
[Severe hepatic veno-occlusive disease (VOD) which was successfully treated with supportive therapy, but subsequently developed late-recurrence].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1998, Volume: 39, Issue:2

    Topics: Adult; Bone Marrow Transplantation; Busulfan; Chronic Disease; Cyclophosphamide; Cyclosporine; Graft vs Host Disease; Hepatic Veno-Occlusive Disease; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Recurrence; Respiratory Distress Syndrome; Tacrolimus

1998
Acquired ichthyosis associated with chronic graft-versus-host disease following allogeneic peripheral blood stem cell transplantation in a patient with chronic myelogenous leukemia.
    Bone marrow transplantation, 1998, Volume: 21, Issue:11

    Topics: Adult; Chronic Disease; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Ichthyosis; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Transplantation, Homologous

1998
Cyclosporin-related reversible muscular toxicity.
    Bone marrow transplantation, 1998, Volume: 22, Issue:1

    Topics: Adult; Creatine Kinase; Cyclosporine; Dose-Response Relationship, Drug; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Muscles

1998
[Rapid tapering of cyclosporine for cytogenetic relapse shortly after bone marrow transplantation in a patient with chronic myeloid leukemia].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1998, Volume: 39, Issue:6

    Topics: Bone Marrow Transplantation; Cyclosporine; Female; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Middle Aged; Philadelphia Chromosome

1998
Complete response in severe thrombotic microangiopathy post bone marrow transplantation (BMT-TM) after multiple plasmaphereses.
    Bone marrow transplantation, 1998, Volume: 22, Issue:10

    Topics: Adult; Anemia, Hemolytic; Bone Marrow Transplantation; Cyclosporine; Hemolytic-Uremic Syndrome; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Plasma; Plasmapheresis; Thrombosis

1998
Antileukemic effects of rapid cyclosporin withdrawal in patients with relapsed chronic myeloid leukemia after allogeneic bone marrow transplantation.
    Leukemia & lymphoma, 1998, Volume: 31, Issue:5-6

    Topics: Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Female; Glucocorticoids; Graft vs Host Disease; Graft vs Tumor Effect; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukocyte Transfusion; Male; Middle Aged; Prednisolone; Recurrence; Remission Induction; Salvage Therapy; Transplantation, Homologous

1998
A new preconditioning regimen with melphalan, busulphan and total body irradiation followed by low-dose immunosuppressant in allogeneic haemopoietic stem cell transplantation.
    British journal of haematology, 1999, Volume: 105, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cyclosporine; Disease-Free Survival; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Melphalan; Middle Aged; Tacrolimus; Whole-Body Irradiation

1999
T-cell depletion plus salvage immunotherapy with donor leukocyte infusions as a strategy to treat chronic-phase chronic myelogenous leukemia patients undergoing HLA-identical sibling marrow transplantation.
    Blood, 1999, Jul-15, Volume: 94, Issue:2

    Topics: Adolescent; Adult; Biomarkers, Tumor; Bone Marrow Transplantation; Cyclosporine; Female; Follow-Up Studies; Fusion Proteins, bcr-abl; Gastrointestinal Hemorrhage; Graft Enhancement, Immunologic; Graft vs Host Disease; Graft vs Tumor Effect; Histocompatibility; HLA Antigens; Humans; Immunosuppressive Agents; Incidence; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Chronic-Phase; Leukocyte Transfusion; Life Tables; Lymphocyte Depletion; Male; Middle Aged; Neoplasm, Residual; Nuclear Family; Polymerase Chain Reaction; Salvage Therapy; Survival Analysis; T-Lymphocytes; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome

1999
Comparison of P-glycoprotein expression and function with in vitro sensitivity to anthracyclines in AML.
    Advances in experimental medicine and biology, 1999, Volume: 457

    Topics: Acridines; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blast Crisis; Bone Marrow; Cell Survival; Cyclosporine; Daunorubicin; Gene Expression Regulation, Neoplastic; Humans; Isoquinolines; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Recurrence; Tetrahydroisoquinolines; Tumor Cells, Cultured

1999
Effect of short-term interferon therapy on the outcome of subsequent HLA-identical sibling bone marrow transplantation for chronic myelogenous leukemia: an analysis from the international bone marrow transplant registry.
    Blood, 2000, Jan-15, Volume: 95, Issue:2

    Topics: Actuarial Analysis; Adolescent; Adult; Bone Marrow Transplantation; Child; Cyclosporine; Disease-Free Survival; Female; Histocompatibility Testing; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Living Donors; Male; Methotrexate; Middle Aged; Multivariate Analysis; Nuclear Family; Registries; Survival Analysis; Transplantation, Homologous

2000
FK506-induced intractable leukoencephalopathy following allogeneic bone marrow transplantation.
    Bone marrow transplantation, 2000, Volume: 25, Issue:3

    Topics: Acute Disease; Adolescent; Child, Preschool; Cyclosporine; Dementia, Vascular; Electroencephalography; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Magnetic Resonance Imaging; Male; Seizures; Tacrolimus

2000
Late onset cyclosporine-induced cerebral blindness with abnormal SPECT imagings in a patient undergoing unrelated bone marrow transplantation.
    Bone marrow transplantation, 2000, Volume: 26, Issue:1

    Topics: Aged; Blindness, Cortical; Bone Marrow Transplantation; Cyclosporine; Female; Frontal Lobe; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Magnetic Resonance Imaging; Occipital Lobe; Remission, Spontaneous; Tomography, Emission-Computed, Single-Photon

2000
Calcium ionophore activation of chronic myelogenous leukemia progenitor cells into dendritic cells is mediated by calcineurin phosphatase.
    Leukemia research, 2000, Volume: 24, Issue:10

    Topics: Calcimycin; Calcium; Calmodulin; Cyclosporine; Dendritic Cells; Humans; Ionophores; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphocyte Activation; Myeloid Progenitor Cells; Phosphoric Monoester Hydrolases; Sulfonamides

2000
Second early allogeneic stem cell transplantations for graft failure in acute leukaemia, chronic myeloid leukaemia and aplastic anaemia. French Society of Bone Marrow Transplantation.
    British journal of haematology, 2000, Volume: 111, Issue:1

    Topics: Adolescent; Adult; Anemia, Aplastic; Chi-Square Distribution; Child; Child, Preschool; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Proportional Hazards Models; Reoperation; Retrospective Studies; Statistics, Nonparametric; Transplantation, Homologous; Treatment Outcome

2000
Inhibition of P-glycoprotein by orange juice components, polymethoxyflavones in adriamycin-resistant human myelogenous leukemia (K562/ADM) cells.
    Cancer letters, 2000, Nov-10, Volume: 160, Issue:1

    Topics: Acetates; ATP Binding Cassette Transporter, Subfamily B; Beverages; Blotting, Western; Citrus; Cyclosporine; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flavones; Flavonoids; Furocoumarins; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Plant Extracts; Tritium; Verapamil; Vincristine

2000
Clinical course and predictive factors for cyclosporin-induced autologous graft-versus-host disease after autologous haematopoietic stem cell transplantation.
    British journal of haematology, 2000, Volume: 111, Issue:3

    Topics: Acute Disease; Adolescent; Adult; Age Factors; Aged; Breast Neoplasms; Chi-Square Distribution; Child; Child, Preschool; Cyclosporine; Disease-Free Survival; Female; Graft vs Leukemia Effect; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; HLA-B Antigens; HLA-DR6 Antigen; Hodgkin Disease; Humans; Immunosuppressive Agents; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multiple Myeloma; Myelodysplastic Syndromes; Prospective Studies; Transplantation, Autologous

2000
Donor lymphocyte infusion followed by interferon-alpha plus low dose cyclosporine A for modulation of donor CD3 cells activity with monitoring of minimal residual disease and cellular chimerism in a patient with first hematologic relapse of chronic myelog
    Leukemia research, 2001, Volume: 25, Issue:4

    Topics: Adolescent; Bone Marrow Transplantation; CD3 Complex; Cyclosporine; Female; Graft vs Leukemia Effect; Humans; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphocyte Transfusion; Neoplasm, Residual; Recurrence; Transplantation Chimera; Transplantation, Homologous

2001
Subarachnoid hemorrhage associated with cyclosporine A neurotoxicity in a bone-marrow transplant recipient.
    Neuroradiology, 2001, Volume: 43, Issue:3

    Topics: Adult; Bone Marrow Transplantation; Brain Edema; Cerebral Angiography; Cyclosporine; Female; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Magnetic Resonance Imaging; Subarachnoid Hemorrhage

2001
Combination therapy with tacrolimus and anti-thymocyte globulin for the treatment of steroid-resistant acute graft-versus-host disease developing during cyclosporine prophylaxis.
    British journal of haematology, 2001, Volume: 113, Issue:1

    Topics: Acute Disease; Adult; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Isoantibodies; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphoma; Male; Methotrexate; Middle Aged; Multiple Myeloma; Myelodysplastic Syndromes; Tacrolimus; Transplantation, Homologous

2001
Eruptive lesions in a patient with bone marrow transplantation.
    International journal of dermatology, 2001, Volume: 40, Issue:2

    Topics: Adult; Biopsy; Bone Marrow Transplantation; Cyclosporine; Graft vs Host Reaction; Humans; Hyperplasia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Sebaceous Glands

2001
Multiple herpes simplex virus infections with various resistance patterns in a matched unrelated donor transplant recipient.
    Bone marrow transplantation, 2001, Volume: 28, Issue:8

    Topics: Acyclovir; Antineoplastic Agents, Alkylating; Antiviral Agents; Bone Marrow Transplantation; Cidofovir; Combined Modality Therapy; Cyclosporine; Cytarabine; Cytomegalovirus Infections; Cytosine; Drug Resistance, Viral; Fatal Outcome; Foscarnet; Graft vs Host Disease; Herpes Genitalis; Herpes Simplex; Humans; Hydroxyurea; Immunocompromised Host; Immunosuppressive Agents; Interferons; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Middle Aged; Organophosphonates; Organophosphorus Compounds; Simplexvirus; Transplantation Conditioning; Whole-Body Irradiation

2001
Intravenous cyclosporine-rifampin interaction in a pediatric bone marrow transplant recipient.
    Pharmacotherapy, 2002, Volume: 22, Issue:3

    Topics: Antibiotics, Antitubercular; Bacteremia; Bone Marrow Transplantation; Child; Cyclosporine; Drug Interactions; Female; Fever; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infusions, Intravenous; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neutropenia; Rifampin; Staphylococcal Infections; Staphylococcus aureus

2002
P-glycoprotein expression in refractory hematological neoplasms and circumvention of resistance with verapamil or cyclosporine A containing protocols.
    Medical oncology and tumor pharmacotherapy, 1992, Volume: 9, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blast Crisis; Carrier Proteins; Cyclosporine; Drug Resistance; Gene Expression; Humans; Immunophenotyping; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Membrane Glycoproteins; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Verapamil

1992
HLA-identical sibling donor bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: influence of GVHD prophylaxis on outcome.
    British journal of haematology, 1992, Volume: 81, Issue:3

    Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Cyclosporine; DNA, Neoplasm; Drug Therapy, Combination; Female; Fusion Proteins, bcr-abl; Graft vs Host Disease; Histocompatibility; HLA Antigens; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Middle Aged; Polymerase Chain Reaction; Prognosis; Recurrence; RNA, Messenger; Transcription, Genetic

1992
Long duration of erythrocyte hypoplasia after bone marrow transplantation.
    Acta paediatrica Japonica : Overseas edition, 1992, Volume: 34, Issue:4

    Topics: ABO Blood-Group System; Adolescent; Blood Group Incompatibility; Bone Marrow Transplantation; Cyclosporine; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Red-Cell Aplasia, Pure

1992
Evidence that sustained growth suppression of intestinal anaerobic bacteria reduces the risk of acute graft-versus-host disease after sibling marrow transplantation.
    Blood, 1992, Nov-15, Volume: 80, Issue:10

    Topics: Adolescent; Adult; Aged; Bacteria, Anaerobic; Bone Marrow Transplantation; Child; Cyclosporine; Family; Female; Graft vs Host Disease; Humans; Intestines; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Middle Aged; Retrospective Studies; Risk Factors; Sex Factors; Tissue Donors

1992
Hematologic relapse of chronic myelogenous leukemia following allogeneic bone marrow transplantation: apparent graft-versus-leukemia effect following abrupt discontinuation of immunosuppression.
    Bone marrow transplantation, 1992, Volume: 10, Issue:4

    Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Cytotoxicity, Immunologic; Graft vs Host Disease; Humans; Immunosuppression Therapy; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphocyte Subsets; Male; Middle Aged; Recurrence; Transplantation, Homologous

1992
Membranous nephropathy with graft-versus-host disease in a bone marrow transplant recipient.
    Clinical nephrology, 1992, Volume: 37, Issue:3

    Topics: Adult; Antibodies, Antinuclear; Biopsy; Bone Marrow Transplantation; Cyclosporine; Fluorescent Antibody Technique; Glomerulonephritis, Membranous; Graft vs Host Disease; Humans; Kidney; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Prednisolone

1992
[The analysis of leukemic relapse after allogeneic bone marrow transplantation].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1991, Volume: 32, Issue:11

    Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Cyclosporine; Female; Graft vs Host Disease; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Postoperative Complications; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Survival Rate; Transplantation, Homologous

1991